Emtricitabine + Tenofovir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Emtricitabine emtricitabine
Tenofovir tenofovir

Brands with this exact combination

Brand	Composition & strength	Manufacturer
DESCOVY 200 mg/10 mg, comprime pelliculéFR	tablet ×2 Emtricitabine 200 mg + Tenofovir	GILEAD SCIENCES IRELAND UC (IRLANDE)
MOVITREMMX	tablet Emtricitabine + Tenofovir	Sandoz, S.A. de C.V.
LUVIREN-PROMX	tablet Emtricitabine + Tenofovir	Hetero Labs Limited
TREWIXMX	tablet Emtricitabine + Tenofovir	Laboratorios Corne, S.A. de C.V.
EZITABRITMX	tablet Emtricitabine + Tenofovir	Protein, S.A. de C.V.
EMTRICITABINE TENOFOVIR DISOPROXIL MYLAN 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir	MYLAN PHARMACEUTICALS (IRLANDE)
EMTRICITABINE/TENOFOVIR DISOPROXIL ACCORD 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300 mg	ACCORD HEALTHCARE FRANCE
EMTRICITABINE/TENOFOVIR DISOPROXIL ARROW 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300 mg	ARROW GENERIQUES
EMTRICITABINE/TENOFOVIR DISOPROXIL BIOGARAN 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300.6 mg	BIOGARAN
EMTRICITABINE/TENOFOVIR DISOPROXIL EG 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300.6 mg	EG LABO - LABORATOIRES EUROGENERICS
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300.7 mg	KRKA (SLOVENIE)
EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA D.D. 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300.7 mg	KRKA (SLOVENIE)
EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 291.22 mg	TEVA SANTE
EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 291.5 mg	ZENTIVA (REPUBLIQUE TCHEQUE)
EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA LAB 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300 mg	ZENTIVA FRANCE
EMTRICITABINE/TENOFOVIR DISOPROXIL ZYDUS 200 mg/245mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300 mg	ZYDUS FRANCE
TRUVADA 200 mg/245 mg, comprimé pelliculéFR	tablet Emtricitabine 200 mg + Tenofovir 300 mg	GILEAD SCIENCES IRELAND UC (IRLANDE)

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.